Safety: Number of patients with adverse events [ Time Frame: 18 months ] [ Designated as safety issue: Yes ]Safety will be evaluated by determining the number of patients with adverse events, including loss of vision, visual field, or retinal/optic nerve structure, and ocular complications such as pain and inflammation.